Glycaemic control modifies the haptoglobin 2 allele-conferred susceptibility to coronary artery disease in Type 1 diabetes

Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial

(2015) Tina Costacou et al.   ACTA DIABETOLOGICA

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Genetic analysis of haptoglobin polymorphisms with cardiovascular disease and type 2 diabetes in the diabetes heart study

(2013) Jeremy N Adams et al.   Cardiovascular Diabetology

Haptoglobin Genotype Is a Consistent Marker of Coronary Heart Disease Risk Among Individuals With Elevated Glycosylated Hemoglobin

(2013) Leah E. Cahill et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Haptoglobin Genotype and Its Role in Diabetic Cardiovascular Disease

(2012) Tina Costacou et al.   Journal of Cardiovascular Translational Research

The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes

(2010) Shany Blum et al.   ATHEROSCLEROSIS

Haptoglobin Genotype: A Determinant of Cardiovascular Complication Risk in Type 1 Diabetes

(2008) T. Costacou et al.   DIABETES

Vitamin E Supplementation Reduces Cardiovascular Events in a Subgroup of Middle-Aged Individuals With Both Type 2 Diabetes Mellitus and the Haptoglobin 2-2 Genotype

(2007) Uzi Milman et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY